Literature DB >> 28616343

Debranching aortic surgery.

Manuel Alonso Pérez1, José Manuel Llaneza Coto1, José Antonio Del Castro Madrazo1, Carlota Fernández Prendes1, Mario González Gay2, Amer Zanabili Al-Sibbai1.   

Abstract

Conventional open surgery still remains as the gold standard of care for aortic arch and thoracoabdominal pathology. In centers of excellence, open repair of the arch has been performed with 5% immediate mortality and a low rate of complications; however overall mortality rates are around 15%, being up to 40% of all patients rejected for treatment due to their age or comorbidities. For thoracoabdominal aortic pathology, data reported from centers of excellence show immediate mortality rates from 5% to 19%, spinal cord ischemia from 2.7% to 13.2%, and renal failure needing dialysis from 4.6% to 5.6%. For these reasons, different alternatives that use endovascular techniques, including debranching procedures, have been developed. The reported results for hybrid debranching procedures are controversial and difficult to interpret because series are retrospective, heterogenic and including a small number of patients. Clearly, an important selection bias exists: debranching procedures are performed in elderly patients with more comorbidities and with thoracoabdominal aortic aneurysms that have more complex and extensive disease. Considering this fact, debranching procedures still remain a useful alternative: for aortic arch pathology debranching techniques can avoid or reduce the time of extracorporeal circulation (ECC) or cardiac arrest which may be beneficial in high-risk patients that otherwise would be rejected for treatment. And compared to pure endovascular techniques, they can be used in emergency cases with applicability in a wide range of anatomies. For thoracoabdominal aortic aneurysms, they are mainly useful when other lesser invasive endovascular options are not feasible due to anatomical limitations or when they are not available in cases where delaying the intervention is not an option.

Entities:  

Keywords:  Aortic; aneurysm; debranching; thoracoabdominal

Year:  2017        PMID: 28616343      PMCID: PMC5462713          DOI: 10.21037/jtd.2017.03.87

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  69 in total

1.  Thoracoabdominal aneurysm repair: hybrid versus open repair.

Authors:  Rajendra Patel; Mark F Conrad; Vikram Paruchuri; Christopher J Kwolek; Thomas K Chung; Richard P Cambria
Journal:  J Vasc Surg       Date:  2009-07       Impact factor: 4.268

2.  Hybrid-procedures for the treatment of thoracoabdominal aortic aneurysms and dissections.

Authors:  M Gawenda; M Aleksic; J Heckenkamp; V Reichert; A Gossmann; J Brunkwall
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-10-23       Impact factor: 7.069

3.  Aortic arch debranching and thoracic endovascular repair.

Authors:  Paola De Rango; Piergiorgio Cao; Ciro Ferrer; Gioele Simonte; Carlo Coscarella; Enrico Cieri; Gabriele Pogany; Fabio Verzini
Journal:  J Vasc Surg       Date:  2013-08-31       Impact factor: 4.268

4.  Postoperative Outcomes of Hybrid Repair in the Treatment of Aortic Arch Aneurysms.

Authors:  Hiroshi Narita; Kimihiro Komori; Akihiko Usui; Kiyohito Yamamoto; Hiroshi Banno; Akio Kodama; Masayuki Sugimoto
Journal:  Ann Vasc Surg       Date:  2016-05-12       Impact factor: 1.466

5.  Arch and visceral/renal debranching combined with endovascular repair for thoracic and thoracoabdominal aortic aneurysms.

Authors:  Sung Wan Ham; Terry Chong; John Moos; Vincent L Rowe; Robbin G Cohen; Mark J Cunningham; Alison Wilcox; Fred A Weaver
Journal:  J Vasc Surg       Date:  2011-02-21       Impact factor: 4.268

6.  The impact of early pelvic and lower limb reperfusion and attentive peri-operative management on the incidence of spinal cord ischemia during thoracoabdominal aortic aneurysm endovascular repair.

Authors:  B Maurel; N Delclaux; J Sobocinski; A Hertault; T Martin-Gonzalez; M Moussa; R Spear; M Le Roux; R Azzaoui; M Tyrrell; S Haulon
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-01-06       Impact factor: 7.069

7.  Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis.

Authors:  Michel S Makaroun; Ellen D Dillavou; Stephen T Kee; Gregorio Sicard; Elliot Chaikof; Joseph Bavaria; David Williams; Richard P Cambria; R Scott Mitchell
Journal:  J Vasc Surg       Date:  2005-01       Impact factor: 4.268

8.  Chimney and periscope grafts observed over 2 years after their use to revascularize 169 renovisceral branches in 77 patients with complex aortic aneurysms.

Authors:  Mario Lachat; Frank J Veith; Thomas Pfammatter; Michael Glenck; Dominique Bettex; Dieter Mayer; Zoran Rancic; Steffen Gloekler; Felice Pecoraro
Journal:  J Endovasc Ther       Date:  2013-10       Impact factor: 3.487

9.  Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease.

Authors:  E S Crawford; R W DeNatale
Journal:  J Vasc Surg       Date:  1986-04       Impact factor: 4.268

10.  Endovascular treatment of thoracoabdominal aortic aneurysms.

Authors:  Matthieu Guillou; Aurelia Bianchini; Jonathan Sobocinski; Blandine Maurel; Piervito D'elia; Mark Tyrrell; Richard Azzaoui; Stéphan Haulon
Journal:  J Vasc Surg       Date:  2012-05-05       Impact factor: 4.268

View more
  1 in total

1.  Intravenous hydrogen sulfide does not induce neuroprotection after aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury in a human-like porcine model of ubiquitous arteriosclerosis.

Authors:  Andre Bredthauer; Karla Lehle; Angelika Scheuerle; Hubert Schelzig; Oscar McCook; Peter Radermacher; Csaba Szabo; Martin Wepler; Florian Simon
Journal:  Intensive Care Med Exp       Date:  2018-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.